Location Cincinnati, Ohio, United States Regions Great Lakes, Midwestern US Gender Male
LinkedIn View on LinkedIn
Gregory Flexter is Chief Executive Officer and Board Member of Blue Ash Therapeutics (BAT). He has 30 years of executive leadership experience in pharmaceuticals product development, clinical research, business development, general management and executive oversight of both domestic and international operations. Having joined BAT at its founding,
he is responsible for the strategic formation, development, funding and growth of theGregory Flexter company. Prior to BAT Mr. Flexter was President, CEO and Executive Board Member of Xanodyne Pharmaceuticals. Mr. Flexter served more than five years with Shire Pharmaceuticals, where he was the Executive VP and General Manager of Shire’s North American operations. Previously he led the Neuroscience Division of Novartis. Mr. Flexter began his career with Marion Laboratories.
